1.The Expression of Defensin-Associated Genes May Be Correlated With Lymph Node Metastasis of Early-Stage Tongue Cancer
Doh Young LEE ; J. Hun HAH ; Woo-Jin JEONG ; Eun-Jae CHUNG ; Tack-Kyun KWON ; Soon-Hyun AHN ; Myung-Whun SUNG ; Seong Keun KWON
Clinical and Experimental Otorhinolaryngology 2022;15(4):372-379
		                        		
		                        			 Objectives:
		                        			. We aimed to assess the genetic differences between cases of early-stage tongue cancer that were positive or negative for lymph node metastasis. 
		                        		
		                        			Methods:
		                        			. In total, 35 cases of tongue cancer with RNA sequencing data were enrolled in this study. The gene expression profile of the following two groups was compared: N0 group (T stage 1 or 2 with N0 stage) and N+ group (T stage 1 or 2 with N+ stage). Using the R and limma packages in the Bioconductor program, we extracted the differentially expressed genes (DEGs). Gene ontology and pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integration Discovery (DAVID) online tool. Immune cell infiltration was analyzed using the CIBERSORT online program. Immunochemical staining of the cancer tissue was evaluated and The Cancer Genome Atlas (TCGA) data were analyzed to validate the identified DEGs. 
		                        		
		                        			Results:
		                        			. No significant differences were found in the infiltration of 22 types of immune cells. Among a total of 51 identified DEGs, 14 genes were significantly upregulated, while 37 genes were significantly downregulated (P<0.01; fold change >2). Pathway analysis revealed significant associations with the arachidonic acid metabolism-related pathway, calcium signaling, and the muscle contraction pathway. The following DEGs were the most significantly different between the two groups: DEFB4A, SPRR2B, DEFB103B, SPRR2G, DEFB4B, and FAM25A. TCGA data showed that DEFB4A and DEFB103B were more highly expressed in the N0 group than in the N+ group, although the difference did not achieve statistical significance. Immunochemical staining of cancer tissue revealed significantly higher expression of defensin in the N0 group. 
		                        		
		                        			Conclusions
		                        			. Defensin (DEFB4A, DEFB103B, DEFB4B) may be a novel biomarker for early regional metastasis in T1/2 tongue cancer. 
		                        		
		                        		
		                        		
		                        	
2.Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo jin JUNG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su jin KIM ; Eun Jae JUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(2):278-286
		                        		
		                        			
		                        			BACKGROUND: The ongoing Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) aims to observe the natural course of papillary thyroid microcarcinoma (PTMC), develop a protocol for active surveillance (AS), and compare the long-term prognosis, quality of life, and medical costs between the AS and immediate surgery groups. METHODS: This multicenter prospective cohort study of PTMC started in June 2016. The inclusion criteria were suspicious of malignancy or malignancy based on fine needle aspiration or core needle biopsy, age of ≥18 years, and a maximum diameter of ≤1 cm. If there was no major organ involvement, no lymph node/distant metastasis, and no variants with poor prognosis, the patients were explained of the pros and cons of immediate surgery and AS before selecting AS or immediate surgery. Follow-up visits (physical examination, ultrasonography, thyroid function, and questionnaires) are scheduled every 6 months during the first 2 years, and then every 1 year thereafter. Progression was defined as a maximum diameter increase of ≥3, ≥2 mm in two dimensions, suspected organ involvement, or lymph node/distant metastasis. RESULTS: Among 439 enrolled patients, 290 patients (66.1%) chose AS and 149 patients (33.9%) chose immediate surgery. The median follow-up was 6.7 months (range, 0.2 to 11.9). The immediate surgery group had a larger maximum tumor diameter, compared to the AS group (7.1±1.9 mm vs. 6.6±2.0 mm, respectively; P=0.014). CONCLUSION: The results will be useful for developing an appropriate PTMC treatment policy based on its natural course and risk factors for progression.
		                        		
		                        		
		                        		
		                        			Biopsy, Fine-Needle
		                        			;
		                        		
		                        			Biopsy, Large-Core Needle
		                        			;
		                        		
		                        			Cohort Studies*
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Prospective Studies*
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Thyroid Gland*
		                        			;
		                        		
		                        			Thyroid Neoplasms
		                        			;
		                        		
		                        			Ultrasonography
		                        			
		                        		
		                        	
3.Corrigendum: Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji Hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo Jin JEONG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su Jin KIM ; Eun Jae CHUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(3):427-427
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        	
4.Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.
Soon Hyun AHN ; Hyun Jun HONG ; Soon Young KWON ; Kee Hwan KWON ; Jong Lyel ROH ; Junsun RYU ; Jun Hee PARK ; Seung Kuk BAEK ; Guk Haeng LEE ; Sei Young LEE ; Jin Choon LEE ; Man Ki CHUNG ; Young Hoon JOO ; Yong Bae JI ; Jeong Hun HAH ; Minsu KWON ; Young Min PARK ; Chang Myeon SONG ; Sung Chan SHIN ; Chang Hwan RYU ; Doh Young LEE ; Young Chan LEE ; Jae Won CHANG ; Ha Min JEONG ; Jae Keun CHO ; Wonjae CHA ; Byung Joon CHUN ; Ik Joon CHOI ; Hyo Geun CHOI ; Kang Dae LEE
Clinical and Experimental Otorhinolaryngology 2017;10(1):1-43
		                        		
		                        			
		                        			Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to develop clinical practice guidelines for the surgical treatment of laryngeal cancer. This Task Force conducted a systematic search of the EMBASE, MEDLINE, Cochrane Library, and KoreaMed databases to identify relevant articles, using search terms selected according to the key questions. Evidence-based recommendations were then created on the basis of these articles. An external expert review and Delphi questionnaire were applied to reach consensus regarding the recommendations. The resulting guidelines focus on the surgical treatment of laryngeal cancer with the assumption that surgery is the selected treatment modality after a multidisciplinary discussion in any context. These guidelines do not, therefore, address non-surgical treatment such as radiation therapy or chemotherapy. The committee developed 62 evidence-based recommendations in 32 categories intended to assist clinicians during management of patients with laryngeal cancer and patients with laryngeal cancer, and counselors and health policy-makers.
		                        		
		                        		
		                        		
		                        			Advisory Committees
		                        			;
		                        		
		                        			Consensus
		                        			;
		                        		
		                        			Counseling
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Glottis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Laryngeal Neoplasms*
		                        			;
		                        		
		                        			Neck*
		                        			
		                        		
		                        	
5.Clinical Features and Outcomes of Patients in Neonatal Intensive Care Requiring Laryngologic Consultation for Airway Disorders.
Jin Youp KIM ; Doh Young LEE ; Hyun CHANG ; Dong Wook KIM ; Myung Whun SUNG ; Jeong Hun HAH
Korean Journal of Otolaryngology - Head and Neck Surgery 2017;60(1):24-29
		                        		
		                        			
		                        			BACKGROUND AND OBJECTIVES: Airway problems frequently occur in neonatal patients requiring intensive care due to high prevalence of intubation history and congenital conditions that are linked to craniofacial or upper aerodigestive tract anomalies. However, many investigations on airway disorders have examined large populations of hospitalized children without focusing on those treated in the intensive care unit (ICU). Here we present the clinical features and outcomes in infants hospitalized with airway-related problems at the neonatal ICU. SUBJECTS AND METHOD: A total 69 patients were studied from May 2005 to December 2012, with each examined by an otolaryngologist while in neonatal ICU (NICU) for possible airway problems. Descriptive analysis was used in evaluating illnesses suffered and subsequent upper airway treatments. Factors associated with tracheostomy were identified by multivariate analysis. RESULTS: The median age of infants was 30 days (range, 1-237 days), with a male-to-female ratio of 1.38. The median gestational age was 35⁺³ weeks, and the mean birth weight was 2.35±0.89 kg. Overall, 40 patients had histories of intubation (median duration, 36 days; range, 1-204 days). The most common diagnosis in the upper airway exam was laryngomalacia (n=12), followed by subglottic stenosis (n=10) and micrognathia (n=8). Tracheostomy was performed in 38 patients (55.1%). In multivariate analysis, intubation history was identified as the only variable demonstrating a significant independent association with tracheostomy (p=0.006). CONCLUSION: Upper airway problems in NICU patients are due to a variety of disorders. Precise diagnosis and treatment is achievable through bedside and intraoperative assessments. Patients with a history of intubation are at increased risk of tracheostomy.
		                        		
		                        		
		                        		
		                        	
6.The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Jin Ho SONG ; Hong Gyun WU ; Bhum Suk KEAM ; Jeong Hun HAH ; Yong Chan AHN ; Dongryul OH ; Jae Myoung NOH ; Hyo Jung PARK ; Chang Geol LEE ; Ki Chang KEUM ; Jihye CHA ; Kwan Ho CHO ; Sung Ho MOON ; Ji Yoon KIM ; Woong Ki CHUNG ; Young Taek OH ; Won Taek KIM ; Moon June CHO ; Chul Seung KAY ; Yeon Sil KIM
Cancer Research and Treatment 2016;48(3):917-927
		                        		
		                        			
		                        			PURPOSE: We compared the treatment results and toxicity in nasopharyngeal carcinoma (NPC) patients treated with concurrent chemotherapy (CCRT) alone (the CRT arm) or neoadjuvant chemotherapy followed by CCRT (the NCT arm). MATERIALS AND METHODS: A multi-institutional retrospective study was conducted to review NPC patterns of care and treatment outcome. Data of 568 NPC patients treated by CCRT alone or by neoadjuvant chemotherapy followed by CCRT were collected from 15 institutions. Patients in both treatment arms were matched using the propensity score matching method, and the clinical outcomes were analyzed. RESULTS: After matching, 300 patients (150 patients in each group) were selected for analysis. Higher 5-year locoregional failure-free survival was observed in the CRT arm (85% vs. 72%, p=0.014). No significant differences in distant failure-free survival (DFFS), disease-free survival (DFS), and overall survival were observed between groups. In subgroup analysis, the NCT arm showed superior DFFS and DFS in stage IV patients younger than 60 years. No significant difference in compliance and toxicity was observed between groups, except the radiation therapy duration was slightly shorter in the CRT arm (50.0 days vs. 53.9 days, p=0.018). CONCLUSION: This study did not show the superiority of NCT followed by CCRT over CCRT alone. Because NCT could increase the risk of locoregional recurrences, it can only be considered in selected young patients with advanced stage IV disease. The role of NCT remains to be defined and should not be viewed as the standard of care.
		                        		
		                        		
		                        		
		                        			Arm
		                        			;
		                        		
		                        			Chemoradiotherapy
		                        			;
		                        		
		                        			Compliance
		                        			;
		                        		
		                        			Disease-Free Survival
		                        			;
		                        		
		                        			Drug Therapy*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Induction Chemotherapy
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Nasopharyngeal Neoplasms
		                        			;
		                        		
		                        			Propensity Score*
		                        			;
		                        		
		                        			Radiotherapy
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Retrospective Studies*
		                        			;
		                        		
		                        			Standard of Care
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
7.VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.
Seongyeol PARK ; Soo Jeong NAM ; Bhumsuk KEAM ; Tae Min KIM ; Yoon Kyung JEON ; Se Hoon LEE ; J Hun HAH ; Tack Kyun KWON ; Dong Wan KIM ; Myung Whun SUNG ; Dae Seog HEO ; Yung Jue BANG
Cancer Research and Treatment 2016;48(2):518-526
		                        		
		                        			
		                        			PURPOSE: The purpose of this study was to evaluate potential prognostic factors in patients with adenoid cystic carcinoma (ACC). MATERIALS AND METHODS: A total of 68 patients who underwent curative surgery and had available tissue were enrolled in this study. Their medical records and pathologic slides were reviewed and immunohistochemistry for basic fibroblast growth factor, fibroblast growth factor receptor (FGFR) 2, FGFR3, c-kit, Myb proto-oncogene protein, platelet-derived growth factor receptor beta, vascular endothelial growth factor (VEGF), and Ki-67 was performed. Univariate and multivariate analysis was performed for determination of disease-free survival (DFS) and overall survival (OS). RESULTS: In univariate analyses, primary site of nasal cavity and paranasal sinus (p=0.022) and Ki-67 expression of more than 7% (p=0.001) were statistically significant factors for poor DFS. Regarding OS, perineural invasion (p=0.032), high expression of VEGF (p=0.033), and high expression of Ki-67 (p=0.007) were poor prognostic factors. In multivariate analyses, primary site of nasal cavity and paranasal sinus (p=0.028) and high expression of Ki-67 (p=0.004) were independent risk factors for poor DFS, and high expression of VEGF (p=0.011) and Ki-67 (p=0.011) showed independent association with poor OS. CONCLUSION: High expression of VEGF and Ki-67 were independent poor prognostic factors for OS in ACC.
		                        		
		                        		
		                        		
		                        			Adenoids*
		                        			;
		                        		
		                        			Carcinoma, Adenoid Cystic*
		                        			;
		                        		
		                        			Disease-Free Survival
		                        			;
		                        		
		                        			Fibroblast Growth Factor 2
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Multivariate Analysis
		                        			;
		                        		
		                        			Nasal Cavity
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Proto-Oncogenes
		                        			;
		                        		
		                        			Receptors, Fibroblast Growth Factor
		                        			;
		                        		
		                        			Receptors, Platelet-Derived Growth Factor
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Vascular Endothelial Growth Factor A*
		                        			
		                        		
		                        	
8.Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands.
Jaemin JEONG ; Hyunjung BAEK ; Yoon Ju KIM ; Youngwook CHOI ; Heekyung LEE ; Eunju LEE ; Eun Sook KIM ; Jeong Hun HAH ; Tack Kyun KWON ; Ik Joon CHOI ; Heechung KWON
Experimental & Molecular Medicine 2013;45(11):e58-
		                        		
		                        			
		                        			Salivary function in mammals may be defective for various reasons, such as aging, Sjogren's syndrome or radiation therapy in head and neck cancer patients. Recently, tissue-specific stem cell therapy has attracted public attention as a next-generation therapeutic reagent. In the present study, we isolated tissue-specific stem cells from the human submandibular salivary gland (hSGSCs). To efficiently isolate and amplify hSGSCs in large amounts, we developed a culture system (lasting 4-5 weeks) without any selection. After five passages, we obtained adherent cells that expressed mesenchymal stem cell surface antigen markers, such as CD44, CD49f, CD90 and CD105, but not the hematopoietic stem cell markers, CD34 and CD45, and that were able to undergo adipogenic, osteogenic and chondrogenic differentiation. In addition, hSGSCs were differentiated into amylase-expressing cells by using a two-step differentiation method. Transplantation of hSGSCs to radiation-damaged rat salivary glands rescued hyposalivation and body weight loss, restored acinar and duct cell structure, and decreased the amount of apoptotic cells. These data suggest that the isolated hSGSCs, which may have characteristics of mesenchymal-like stem cells, could be used as a cell therapy agent for the damaged salivary gland.
		                        		
		                        		
		                        		
		                        			Amylases/genetics/metabolism
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antigens, CD/genetics/metabolism
		                        			;
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Cell Differentiation
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mesenchymal Stromal Cells/*cytology/metabolism
		                        			;
		                        		
		                        			Radiation Injuries, Experimental
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Rats, Wistar
		                        			;
		                        		
		                        			*Regeneration
		                        			;
		                        		
		                        			Salivary Glands/cytology/injuries/physiology/*surgery
		                        			;
		                        		
		                        			*Salivation
		                        			;
		                        		
		                        			*Stem Cell Transplantation
		                        			
		                        		
		                        	
9.A Case of Pyriform Sinus Perforation Secondary to Traumatic Intubation.
Yoon Seok CHOI ; Woo Jin JEONG ; J Hun HAH
Korean Journal of Otolaryngology - Head and Neck Surgery 2010;53(12):795-797
		                        		
		                        			
		                        			Traumatic pyriform sinus perforation is a very rare complication of endotracheal intubation. Forced insertion of endotracheal tube can tear pyriform sinus mucosa. Pyriform sinus perforation can result in deep neck infection which may be potentially lethal. We report a case of pyriform sinus perforation secondary to traumatic intubation, which was successfully treated with primary closure.
		                        		
		                        		
		                        		
		                        			Intubation
		                        			;
		                        		
		                        			Intubation, Intratracheal
		                        			;
		                        		
		                        			Mucous Membrane
		                        			;
		                        		
		                        			Neck
		                        			;
		                        		
		                        			Pyriform Sinus
		                        			
		                        		
		                        	
10.Reflux Symptom Index(RSI) and Reflux Finding Score(RFS) of Persons Taking Health Checkup and Their Relationship with Gastrofiberscopic Findings.
Young Ho JUNG ; Dong Yeop CHANG ; Jeong Hoon JANG ; Eun Jung JUNG ; Hun HAH ; Myung Whun SUNG ; Kwang Hyun KIM ; Tack Kyun KWON
Korean Journal of Otolaryngology - Head and Neck Surgery 2007;50(5):431-437
		                        		
		                        			
		                        			BACKGROUND AND OBJECTIVES: Few studies were performed regarding laryngopharyngeal reflux symptoms and reflux findings in persons taking health checkup. The purpose of this study was to evaluate laryngopharyngeal reflux symptom index (RSI) and reflux finding score (RFS) at a healthcare center and their relationship with gastrofiberscopic findings. SUBJECTS AND METHOD: This study included 157 persons taking healthcare program which contained laryngoscopic examination between February 2006 and June 2006. The data of each patients were collected by questionnaire, fill-up sheets of laryngoscopic findings and a retrospective review of medical record. RESULTS: The male to female ratio was about 4 : 1. The mean age was 47 years. The mean values of RSI and RFS were 2.95 and 3.85. Seven (4.5%) persons had RSI more than 13, and 31 (19.7%) persons had RFS more than 7. On gastrofiberscopy, 23 (14.6%) persons had reflux esophagitis, and their RSI were significantly higher than those who did not have reflux esophagitis, and had frequent gastroesophageal reflux symptoms. In persons with abnormal RSI or RFS, only 29% had reflux esophagitis on gastrofiberscopy. Age was inversely related with RSI and smoking was positively related with RFS. CONCLUSION: We suggest that if a person was found to have abnormally elevated RSI or RFS, a diagnostic evaluation for LPR should be considered irrespective of the presence of reflux esophagitis on gastrofiberscopy. In a person with reflux esophagitis on gastrofiberscopy, he or she showed high RSI without any significant differences in RFS : this may have been because the RSI questionnaire included the gastroesophageal reflux symptom item.
		                        		
		                        		
		                        		
		                        			Delivery of Health Care
		                        			;
		                        		
		                        			Esophagitis
		                        			;
		                        		
		                        			Esophagitis, Peptic
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gastroesophageal Reflux
		                        			;
		                        		
		                        			Gastroscopy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Laryngitis
		                        			;
		                        		
		                        			Laryngopharyngeal Reflux
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Smoke
		                        			;
		                        		
		                        			Smoking
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail